Literature DB >> 31982505

The differential neurologic prognosis of low-flow time according to the initial rhythm in patients who undergo extracorporeal cardiopulmonary resuscitation.

Ryoung-Eun Ko1, Jeong-Am Ryu1, Yang Hyun Cho2, Kiick Sung2, Kyeongman Jeon3, Gee Young Suh3, Taek Kyu Park4, Joo Myung Lee4, Young Bin Song4, Joo-Yong Hahn4, Jin-Ho Choi4, Seung-Hyuk Choi4, Hyeon-Cheol Gwon4, Keumhee C Carriere5, Joonghyun Ahn6, Jeong Hoon Yang7.   

Abstract

BACKGROUND: Limited data is available on the association between low-flow time and neurologic outcome according to the initial arrest rhythm in patients underwent extracorporeal cardiopulmonary resuscitation (ECPR).
METHODS: Between September 2004 and December 2018, 294 patients with in-hospital cardiac arrest (IHCA) were included in this analysis. We classified the patients into asystole (n = 42), pulseless electrical activity (PEA, n = 163) and shockable rhythm (n = 89) according to their initial rhythm. Primary outcome was poor neurologic outcome defined as Cerebral Performance Categories scores of 3, 4, and 5.
RESULTS: One-hundred ninety IHCA patients (64.6%) had poor neurologic outcomes. There was significantly worse neurologic outcomes among IHCA patients according to their initial rhythm (asystole [88.1%], PEA [66.3%], and shockable rhythm [50.6%], p < 0.001). The PEA group and the shockable rhythm group showed a significant association between low-flow time and neurologic outcomes while this relationship was not observed in the asystole group: PEA [ρ = 0.224, p = 0.005], shockable rhythm [ρ = 0.298, p = 0.006]), and asystole [ρ = -0.091, p = 0.590]. The best discriminative CPR to pump-on time for neurologic outcome was 22 min in the PEA group (area under the curve 0.687, 95% confidence interval [CI] 0.610-0.758, p < 0.001) and 46 min in the shockable rhythm group (area under the curve 0.671, 95% CI 0.593-0.743, p < 0.001).
CONCLUSIONS: The effect of interplay between arrest rhythm and low-flow time might be helpful for decisions about team activation and management for ECPR and could provide information for early neurologic prognosis.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arrest rhythm; Cardiopulmonary arrest; Extracorporeal membrane oxygenator

Mesh:

Year:  2020        PMID: 31982505     DOI: 10.1016/j.resuscitation.2020.01.015

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  5 in total

1.  The Impact of Hypoxic Hepatitis on Clinical Outcomes after Extracorporeal Cardiopulmonary Resuscitation.

Authors:  Yun Im Lee; Min Goo Kang; Ryoung-Eun Ko; Taek Kyu Park; Chi Ryang Chung; Yang Hyun Cho; Kyeongman Jeon; Gee Young Suh; Jeong Hoon Yang
Journal:  J Clin Med       Date:  2020-09-16       Impact factor: 4.241

2.  Nosocomial infections in in-hospital cardiac arrest patients who undergo extracorporeal cardiopulmonary resuscitation.

Authors:  Ryoung-Eun Ko; Kyungmin Huh; Dong-Hoon Kim; Soo Jin Na; Chi Ryang Chung; Yang Hyun Cho; Kyeongman Jeon; Gee Young Suh; Jeong Hoon Yang
Journal:  PLoS One       Date:  2020-12-23       Impact factor: 3.240

3.  Optimal Arterial Blood Gas Tensions for the Prognosis of Favorable Neurological Outcomes in Survivors after Extracorporeal Cardiopulmonary Resuscitation.

Authors:  SungMin Hong; Ji Hoon Jang; Jeong Hoon Yang; Yang Hyun Cho; Joonghyun Ahn; Jeong-Am Ryu
Journal:  J Clin Med       Date:  2022-07-20       Impact factor: 4.964

4.  Clinical Significance of Low-Flow Time in Patients Undergoing Extracorporeal Cardiopulmonary Resuscitation: Results from the RESCUE Registry.

Authors:  Ik Hyun Park; Jeong Hoon Yang; Woo Jin Jang; Woo Jung Chun; Ju Hyeon Oh; Yong Hwan Park; Cheol Woong Yu; Hyun-Joong Kim; Bum Sung Kim; Jin-Ok Jeong; Hyun Jong Lee; Hyeon-Cheol Gwon
Journal:  J Clin Med       Date:  2020-11-07       Impact factor: 4.241

Review 5.  Extracorporeal cardiopulmonary resuscitation in adults: evidence and implications.

Authors:  Arthur S Slutsky; Alain Combes; Daniel Brodie; Darryl Abrams; Graeme MacLaren; Roberto Lorusso; Susanna Price; Demetris Yannopoulos; Leen Vercaemst; Jan Bělohlávek; Fabio S Taccone; Nadia Aissaoui; Kiran Shekar; A Reshad Garan; Nir Uriel; Joseph E Tonna; Jae Seung Jung; Koji Takeda; Yih-Sharng Chen
Journal:  Intensive Care Med       Date:  2021-09-10       Impact factor: 17.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.